HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Urinary Bladder Diseases (Bladder Diseases)

Subscribe to New Research on Urinary Bladder Diseases

Share|Follow on Twitter

Pathological processes of the URINARY BLADDER.

Also Known As:

Bladder Diseases; Bladder Disease; Urinary Bladder Disease

Networked: 82 relevant articles (4 outcomes, 8 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Pain (Aches)
2.	Infection
3.	Dysuria
4.	Nocturia
5.	Pseudomonas Infections

Experts

1.	Chancellor, Michael B: 3 articles (08/2009 - 12/2006)
2.	Yoshimura, Naoki: 2 articles (08/2009 - 02/2009)
3.	Philips, Brian J: 2 articles (08/2009 - 02/2009)
4.	Ercan, Feriha: 2 articles (12/2008 - 01/2008)
5.	Sun, Biying: 1 article (02/2010)
6.	Rong, Weifang: 1 article (02/2010)
7.	Li, Qian: 1 article (02/2010)
8.	Dong, Li: 1 article (02/2010)
9.	Morrisroe, Shelby N: 1 article (08/2009)
10.	Coyle, Christian H: 1 article (08/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Urinary Bladder Diseases:

1.	Cimetidine (Biomet)FDA LinkGeneric 09/01/2001 - "Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial." 02/01/2001 - "Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial." 02/01/2001 - "OBJECTIVE: To evaluate the efficacy of oral cimetidine as a treatment for painful bladder disease (PBD, variously described as a 'symptom complex' of suprapubic pain, frequency, dysuria and nocturia in the absence of overt urine infection) by assessing symptom relief and histological changes in the bladder wall tissue components, compared with placebo. " Order ALL the reference details at left...
2.	Norfloxacin FDA Link 02/21/1986 - "Patients with neurological bladder disease were cured in a relatively high percentage of their Pseudomonas infection after three months treatment with norfloxacin. " Order ALL the reference details at left...
3.	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/01/1992 - "In this case, only cyclophosphamide markedly improved the protein-losing enteropathy but did not influence the bladder disease." Order ALL the reference details at left...
4.	GlycosaminoglycansIBA 02/01/1994 - "Polysaccharide therapy for bladder disease is a novel therapy based on the model of bladder mucus activity and the belief that mucus and exogenous glycosaminoglycans (GAG) have protective properties. " 02/01/1997 - "The long-term objective of this study is to elucidate the role of bladder mucosal glycosaminoglycans and mucin glycoproteins in the development of interstitial cystitis and other bladder diseases. " Order ALL the reference details at left...
5.	CreatinineIBA 01/01/1996 - "RESULTS: None of the 52 patients with benign conditions, nine of the 27 with Ta-T1, and nine of the 25 with T2-T4 bladder disease had urinary total beta-hCG levels > 3.74 IU/mmol/L creatinine. " 01/01/1993 - "In a cross-section study the levels of urine laminin P1 expressed as a laminin P1:creatinine ratio were determined in 25 patients with superficial (noninvasive) transitional cell carcinoma (TCC) of the bladder, 12 patients with invasive TCC, 15 patients with inflammatory bladder diseases and 50 healthy controls. " Order ALL the reference details at left...
6.	Protein Isoforms (Isoforms)IBA 08/01/2001 - "AIMS: To study the expression of the endothelial and inducible isoforms of nitric oxide synthase (eNOS and iNOS, respectively) in human bladder carcinoma and schistosomal bladder disease, and to compare it with normal adult and fetal urothelium. " Order ALL the reference details at left...
7.	Nitric Oxide Synthase (NO Synthase)IBA 08/01/2001 - "AIMS: To study the expression of the endothelial and inducible isoforms of nitric oxide synthase (eNOS and iNOS, respectively) in human bladder carcinoma and schistosomal bladder disease, and to compare it with normal adult and fetal urothelium. " Order ALL the reference details at left...
8.	MucinsIBA 02/01/1997 - "The long-term objective of this study is to elucidate the role of bladder mucosal glycosaminoglycans and mucin glycoproteins in the development of interstitial cystitis and other bladder diseases. " Order ALL the reference details at left...
9.	Glycoproteins (Glycoprotein)IBA 02/01/1997 - "The long-term objective of this study is to elucidate the role of bladder mucosal glycosaminoglycans and mucin glycoproteins in the development of interstitial cystitis and other bladder diseases. " Order ALL the reference details at left...
10.	AutoantibodiesIBA 07/01/1996 - "In an initial study of anti-nuclear antibodies in the chronic inflammatory bladder disease interstitial cystitis, we reported that 7% of interstitial cystitis patients studied had autoantibodies to the nucleolus. " Order ALL the reference details at left...

Therapies and Procedures

1.	Endoscopes 01/01/1989 - "[The efficacy of rigid and flexible endoscopes in the diagnosis of bladder diseases]" 11/01/2003 - "[Experience in the clinical application of semirigid mini-urethral endoscopes in the diagnosis and treatment of urinary bladder diseases]" 01/01/1989 - "A comparative assessment of the efficiency of rigid and flexible endoscopes used for the diagnosis of bladder diseases (cystitis, papilloma, carcinoma in a total of 250 patients) is reported. " Order ALL the reference details at left...
2.	Radiotherapy 04/01/2009 - "CONCLUSIONS: Historic comparisons with other studies indicate no evidence of an increase in severe or worse adverse events and good permanent control of bladder disease after ARCON radiotherapy." 01/01/1993 - "An interesting observation was the good response seen in patients with recurrent bladder disease who had previously received radial radiotherapy. " 01/01/1985 - "A double-blind study with Serocytol "Muqueuse urinaire" (immune serum against mucosa of the urinary tract) and Serocytol "S.R.E." (immune serum against reticulo-endothelial system) and placebo was designed for treatment of different bladder diseases (interstitial cystitis sui generis, after radiotherapy and in connection with multiple transurethral resections of bladder tumour, cystitis granularis). " Order ALL the reference details at left...
3.	Ambulatory Care (Outpatient Care) 01/01/1985 - "[Cytologic studies in the diagnosis and outpatient care of patients with precancerous bladder diseases]" Order ALL the reference details at left...
4.	Cystectomy 04/01/2009 - "CONCLUSIONS: The newly devised, internally validated, algorithm was 85% accurate in predicting nonorgan-confined bladder disease before cystectomy. " 04/01/2003 - "OBJECTIVES: To evaluate modified cystectomy with preservation of erectile and ejaculatory functions in men with nonmalignant bladder disease. " 04/01/2003 - "[Modified cystectomy with preservation of erectile and ejaculatory functions in men with nonmalignant bladder disease]" 10/01/2001 - "Of 55 patients with recurrent muscle invasive bladder disease 41% and 18% survived when cystectomy was performed within and after 2 years, respectively. " 09/01/2001 - "The experiments have shown that urinary reservoir, serous-muscular constrictor, invagination valve of the urinary reservoir and invagination-valvular ureterocystoanastomosis retain their shape, structure and functional capacity in different postoperative terms and can be practiced in inpatients after radical cystectomy for muscular-invasive cancer of the bladder or in urinary bladder diseases urging greater capacity of the bladder." Order ALL the reference details at left...
5.	Transplants (Transplant) 02/01/2003 - "The development of cancer on the ileal graft after augmentation ileocystoplasty for benign bladder disease is a little known complication. " 06/01/1999 - "The development of cancer on the ileal graft after augmentation ileocystoplasty benign bladder disease is a little known complication. " Order ALL the reference details at left...

blog comments powered by Disqus

TREATMENT OPTIONS
for Urinary Bladder Diseases,
Ranking and Evidence

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 4 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>